Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||1.90%||8.03||0.7%||$561.33m|
|GILD||Gilead Sciences, Inc.||0.72%||65.77||1.0%||$463.29m|
|REGN||Regeneron Pharmaceuticals, Inc.||2.80%||494.64||2.7%||$449.68m|
|VRTX||Vertex Pharmaceuticals, Inc.||1.83%||221.10||1.9%||$383.88m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.45%||157.54||2.0%||$298.86m|
|EXAS||EXACT Sciences Corp.||2.66%||130.52||18.4%||$192.20m|
|NBIX||Neurocrine Biosciences, Inc.||-0.05%||95.00||4.9%||$177.73m|
|CRSP||CRISPR Therapeutics AG||0.60%||123.85||0.6%||$174.50m|
Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.